Verastem (VSTM) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

VSTM Verastem

Watchlist

4.9100
-0.0900-1.80%

Close Dec 11 16:00 ET

4.7600
-0.1500-3.05%

Pre 08:00 ET

218.53MMarket Cap-1.56P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Verastem Oncology to Present at the 7th Annual Evercore ISI HealthCONx Conference
BusinesswireNov 26 07:00 ET
Verastem Inc. Reports Increased Operating Expenses and Net Loss
TipRanksNov 21 22:54 ET
Byondis Appoints Louis Denis, M.D., as Chief Medical Officer
BusinesswireNov 19 01:11 ET
RBC Capital Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $13
Moomoo NewsNov 7 07:31 ET · Ratings
A. G. P. Maintains Verastem(VSTM.US) With Buy Rating, Cuts Target Price to $14
Moomoo NewsNov 7 07:31 ET · Ratings
Verastem Price Target Lowered to $14 From $20 at Alliance Global Partners
TipRanksNov 7 07:06 ET

Comments

$Verastem (VSTM.US)$
If you had bought on 10/31 my last comment, you'd be up 30% now, grats

$Verastem (VSTM.US)$
Pretty damn good run so far. I only managed to hop on in Sept.

1

$Verastem (VSTM.US)$
Verastem Oncology Completes Rolling NDA Submission to the FDA for Avutometinib Plus Defactinib as a Treatment for Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
Verastem Oncology (VSTM) has completed its rolling New Drug Application (NDA) to the FDA for avutometinib plus defactinibcombination therapy for adults with recurrent KRAS mutant low-grade serous ovarian cancer (LGSOC). The company is seeking accelerated approval and priority review, with a potential FDA ap...

MARKET-TEST-DUMMY

$Verastem (VSTM.US)$

Webcast today. Possible PR Monday.

$Verastem (VSTM.US)$

1

1

Read more

US

Overall

No Data